OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
Craig D. Hughes, Minee L. Choi, Mina Ryten, et al.
Acta Neuropathologica (2018) Vol. 137, Iss. 1, pp. 103-120
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Role of neuroinflammation in neurodegeneration development
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 555

The Role of α-Synuclein Oligomers in Parkinson’s Disease
Xiaoyu Du, Xi-xiu Xie, Rui‐tian Liu
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8645-8645
Open Access | Times Cited: 169

Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
Urmi Sengupta, Rakez Kayed
Progress in Neurobiology (2022) Vol. 214, pp. 102270-102270
Open Access | Times Cited: 166

The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
Arash Heidari, Niloufar Yazdanpanah, Nima Rezaei
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 154

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease
Derya Emin, Yu P. Zhang, Evgeniia Lobanova, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 123

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
Yunna Li, Yun Xia, Sijia Yin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 116

Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
Roberta Cascella, Alessandra Bigi, Nunilo Cremades, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 71

SARS-CoV-2 infection causes dopaminergic neuron senescence
Liuliu Yang, Tae Wan Kim, Yuling Han, et al.
Cell stem cell (2024)
Open Access | Times Cited: 64

Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s disease
Qiankun Lv, Kang‐Xin Tao, Xiaobo Wang, et al.
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 443-462
Closed Access | Times Cited: 51

Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
Grace m. Kuo, Ramhari Kumbhar, W. Frank Blair, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 3

Glia Crosstalk in Neuroinflammatory Diseases
Ada Bernaus, Sandra Blanco, Ana Sevilla
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 124

Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
Yoo Jin Jung, David Tweedie, Michael T. Scerba, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 115

Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Caiyun Liu, Xu Wang, Chang Liu, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 114

Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies
Antonina Kouli, C.B. Horne, Caroline H. Williams‐Gray
Brain Behavior and Immunity (2019) Vol. 81, pp. 41-51
Open Access | Times Cited: 110

α‐synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson’s disease
Hai‐Yue Tu, Baoshi Yuan, Xiao‐Ou Hou, et al.
Aging Cell (2021) Vol. 20, Iss. 12
Open Access | Times Cited: 100

Monomeric α-synuclein induces blood–brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro
Shinya Dohgu, Fuyuko Takata, Junichi Matsumoto, et al.
Microvascular Research (2019) Vol. 124, pp. 61-66
Closed Access | Times Cited: 95

Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
Erskine Chu, Richelle Mychasiuk, Margaret L. Hibbs, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 87

Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2
Yun Xia, Guoxin Zhang, Liang Kou, et al.
Brain (2021) Vol. 144, Iss. 7, pp. 2024-2037
Open Access | Times Cited: 86

Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death
Craig D. Hughes, Minee L. Choi, Jee Hyun Yi, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 83

Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis
Yuling Liu, Chia‐Chi Hsu, Hui-Ju Huang, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 1, pp. 96-104
Closed Access | Times Cited: 82

Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression
Suman De, Daniel R. Whiten, Francesco Simone Ruggeri, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 78

Alterations in Blood Monocyte Functions in Parkinson's Disease
Sara Konstantin Nissen, Kalpana Shrivastava, Claudia Schulte, et al.
Movement Disorders (2019) Vol. 34, Iss. 11, pp. 1711-1721
Closed Access | Times Cited: 78

Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders
Yam Nath Paudel, Efthalia Angelopoulou, Bridgette D. Semple, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 4, pp. 485-500
Closed Access | Times Cited: 73

TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut
Anastazja M. Gorecki, Chidozie C. Anyaegbu, Ryan S. Anderton
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 73

Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions
Silvia Squillace, Daniela Salvemini
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 726-739
Open Access | Times Cited: 56

Page 1 - Next Page

Scroll to top